Nicorette Invisi Transdermal Patch 15mg/16 hours

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Nopērc to tagad

Lietošanas instrukcija Lietošanas instrukcija (PIL)
23-12-2020
Produkta apraksts Produkta apraksts (SPC)
22-03-2021

Aktīvā sastāvdaļa:

NICOTINE

Pieejams no:

JOHNSON & JOHNSON SDN BHD

SNN (starptautisko nepatentēto nosaukumu):

NICOTINE

Vienības iepakojumā:

7 Pieces

Ražojis:

LTS LOHMANN THERAPIE-SYSTEM AG

Lietošanas instrukcija

                                NICORETTE
® INVISI TRANSDERMAL PATCH
Nicotine (10mg/16hr, 15mg/16hr and 25mg/16hr)
1
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1.
What Nicorette
®
Invisi
Transdermal Patch is used for
2.
How Nicorette
®
Invisi
Transdermal Patch works
3.
Before you use Nicorette
®
Invisi
Transdermal Patch
4.
How to use Nicorette
®
Invisi
Transdermal Patch
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
Nicorette
®
Invisi Transdermal
Patch
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
WHAT NICORETTE
® INVISI TRANSDERMAL
PATCH
IS USED FOR
Nicorette
®
Invisi Transdermal Patch is
used to relieve withdrawal symptoms
and reduce the cravings for nicotine that
you get when you try to stop smoking,
or when you are cutting down the
number of cigarettes you smoke while
trying to stop smoking.
HOW NICORETTE
® INVISI TRANSDERMAL
PATCH
WORKS
When you stop smoking, or cut down
the number of cigarettes you smoke,
your body misses the nicotine that you
have been absorbing. You may
experience unpleasant feelings and a
strong desire to smoke (craving). This
indicates you were dependent on
nicotine.
When you apply a Nicorette
®
Invisi
Transdermal Patch to the skin, nicotine
is released and passes into your body.
The nicotine released from the patch is
sufficient to relieve the unpleasant
withdrawal symptoms. It will also help
to stop the craving to smoke, but
Nicorette
®
Invisi Transdermal Patch
will not give you the “buzz” you get
from smoking a cigarette.
BEFORE YOU USE NICORETTE
® INVISI
TRANSDERMAL PATCH
-
_When you must not use it _
Do not use
•
If you have an allergy to nicotine or
any of the other ingredients.
•
If you are pregnant, trying to get
pregnant or think you may be
pregnant.
•
If you are breast-feeding. Ask your
doctor or pharmacist for advice.
_ _
-
_Before you start to use it _
Talk to your doctor or pharmacist
•
If you have experienced a serious
cardiovascular event (heart
disease), or hospitalization for
card
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                PRODUCT
BRAND
COMPONENT CODE
VERSION
DESIGN
REPLACED COMP CODE
MARKET
DIELINE / TECH DRAWING REFERENCE
COLOR
ADDITIONAL
INFORMATION
239x490 mm - 2 pages
MY
6509134
6512464
InvisiPatch Leaflet
NICORETTE
SPRUCE
LKL-f
9 pkt
BLACK
FONTSIZE
PDD McNeil, HBG, SWE October 22, 2017 12:28:44
For Healthcare Professionals Use Only
Nicorette
®
Invisi Transdermal Patch
NAME OF THE PRODUCT
Nicorette
®
Invisi Transdermal Patch 10mg/16 Hours.
Nicorette
®
Invisi Transdermal Patch 15mg/16 Hours.
Nicorette
®
Invisi Transdermal Patch 25mg/16 Hours.
ACTIVE INGREDIENT
Nicotine 1.75mg/cm
2
INACTIVE INGREDIENTS
Medium chain triglycerides, basic butylated methacrylate copolymer,
polyethy-
lenterephthalate film (PET), acrylic adhesive solution, potassium
hydroxide,
croscarmellose sodium, aluminium acetylacetonate, siliconized PET
release
liner with aluminized single side.
PHARMACEUTICAL FORM
Transparent patch for topical application available in sizes of 22.5cm
2
/
13.5cm
2
/ 9.0cm
2
.
Nicorette
®
Invisi Transdermal Patch is a beige, semi-transparent/clear patch
consisting of pre-coated backing layer, nicotine source layer, and a
skin contact
adhesive layer on a pre-coated aluminized and siliconized release
liner.
PHARMACOLOGY
Pharmacodynamics
Pharmacotherapeutic group: Drug used in nicotine dependence.
ATC code: N07B A01
Abrupt cessation of the established, regular use of tobacco-containing
products results in the characteristic syndrome, with withdrawal
symptoms
including cravings (urges to smoke) as described below :
Regardless of the means used, a variety of symptoms are known to be
associa-
ted with quitting habitual tobacco use. These include emotional or
cognitive
effects such as dysphoria or depressed mood; insomnia; irritability,
frustration
or anger; anxiety;difficulty concentrating, and restlessness or
impatience. There
may also be physical effects such as decreased heart rate; increased
appetite
or weight gain, dizziness or presyncopal symptoms, cough,
constipation,
gingival bleeding or apthous ulceration,or nasopharyngiti
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija malajiešu 23-12-2020

Meklēt brīdinājumus, kas saistīti ar šo produktu